ES2091369T3 - Antibioticos glucopeptidicos derivados de balhimicina. - Google Patents

Antibioticos glucopeptidicos derivados de balhimicina.

Info

Publication number
ES2091369T3
ES2091369T3 ES92110823T ES92110823T ES2091369T3 ES 2091369 T3 ES2091369 T3 ES 2091369T3 ES 92110823 T ES92110823 T ES 92110823T ES 92110823 T ES92110823 T ES 92110823T ES 2091369 T3 ES2091369 T3 ES 2091369T3
Authority
ES
Spain
Prior art keywords
balhimycin
compound
formula
glucopeptidic
antibiotics derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92110823T
Other languages
English (en)
Inventor
Laszlo Dr Vertesy
Joachim Dr Betz
Hans-Wolf Dr Fehlhaber
Michael Dr Limbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4121662A external-priority patent/DE4121662A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2091369T3 publication Critical patent/ES2091369T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

TIENE EFECTO ANTIBIOTICO EL METIL MBINACION DE LA FORMULA C65 H71 CL2 N9 O24, EL METILLEUCIL BALHIMICIN Y UNA COMPOSICION DE LA FORMULA C59 H60 CL2 N8 O23, EL GLUCO L2 N9 O19, UREIDO LA C67 H74 CL2 N10 O25, EL METIL 5 Y UNA COMPOSICION DE LA FORMULA C73 H84 CL2 N10 O26, UNA COMPOSICION METIL BALHIMICIIN R DE UNA COMPOSICION DE LA FORMULA C72 H83 CL2 N9 O28.
ES92110823T 1991-06-29 1992-06-26 Antibioticos glucopeptidicos derivados de balhimicina. Expired - Lifetime ES2091369T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4121662A DE4121662A1 (de) 1991-06-29 1991-06-29 Neue glycopeptide, verfahren zu ihrer herstellung und ihre verwendung
DE4134611 1991-10-19

Publications (1)

Publication Number Publication Date
ES2091369T3 true ES2091369T3 (es) 1996-11-01

Family

ID=25905082

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92110823T Expired - Lifetime ES2091369T3 (es) 1991-06-29 1992-06-26 Antibioticos glucopeptidicos derivados de balhimicina.

Country Status (23)

Country Link
US (1) US5763397A (es)
EP (1) EP0521408B1 (es)
JP (1) JP2959911B2 (es)
KR (1) KR100243962B1 (es)
AT (1) ATE142226T1 (es)
AU (2) AU660682B2 (es)
CA (1) CA2072725A1 (es)
CZ (1) CZ284310B6 (es)
DE (1) DE59207033D1 (es)
DK (1) DK0521408T3 (es)
ES (1) ES2091369T3 (es)
FI (1) FI106032B (es)
GR (1) GR3021042T3 (es)
HR (1) HRP920191B1 (es)
HU (1) HU214057B (es)
IE (1) IE74901B1 (es)
IL (1) IL102326A (es)
NO (1) NO306950B1 (es)
NZ (1) NZ243345A (es)
RU (1) RU2099349C1 (es)
SI (1) SI9200126A (es)
TW (1) TW213468B (es)
YU (1) YU48512B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19523394A1 (de) * 1995-06-28 1997-01-09 Hoechst Ag Verwendung von Balhimycin zur Leistungssteigerung bei Tieren sowie leistungssteigernde Mittel
US5977063A (en) * 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
US5919771A (en) * 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
US5952310A (en) * 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
DE19926770A1 (de) 1999-06-11 2000-12-14 Basf Ag Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
EP1908770B2 (en) * 2000-12-18 2015-07-15 Cubist Pharmaceuticals, Inc. Methods for preparing purified lipopeptides
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
US8835382B2 (en) 2009-11-23 2014-09-16 Cubist Pharmaceuticals, Inc. Lipopeptide compositions and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
DE3420596C2 (de) * 1984-06-01 1986-10-02 Dr.-Ing. Ludwig Pietzsch Gmbh & Co, 7505 Ettlingen Überwachungs- und Steuersystem für Auslegerkrane
JPH0662674B2 (ja) * 1985-01-11 1994-08-17 三共株式会社 抗生物質クロロポリスポリンｂまたはｃ
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
DE3713757A1 (de) * 1987-04-24 1988-11-10 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
NZ236393A (en) * 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
IN171883B (es) * 1990-07-27 1993-01-30 Hoechst India

Also Published As

Publication number Publication date
DK0521408T3 (es) 1997-01-20
HU214057B (en) 1997-12-29
KR930000537A (ko) 1993-01-15
DE59207033D1 (de) 1996-10-10
HRP920191B1 (en) 1997-12-31
HRP920191A2 (hr) 1994-04-30
FI922954A0 (fi) 1992-06-25
RU2099349C1 (ru) 1997-12-20
NO922520L (no) 1992-12-30
EP0521408B1 (de) 1996-09-04
JPH05271284A (ja) 1993-10-19
EP0521408A1 (de) 1993-01-07
IL102326A (en) 1996-07-23
JP2959911B2 (ja) 1999-10-06
IE922115A1 (en) 1992-12-30
AU3308995A (en) 1996-01-25
CZ284310B6 (cs) 1998-10-14
NO922520D0 (no) 1992-06-26
AU687612B2 (en) 1998-02-26
FI922954A (fi) 1992-12-30
IE74901B1 (en) 1997-08-13
AU1857592A (en) 1993-01-07
HUT63462A (en) 1993-08-30
US5763397A (en) 1998-06-09
NZ243345A (en) 1994-09-27
IL102326A0 (en) 1993-01-14
YU48512B (sh) 1998-09-18
CZ199192A3 (en) 1993-01-13
HU9202163D0 (en) 1992-10-28
YU60392A (sh) 1994-09-09
GR3021042T3 (en) 1996-12-31
CA2072725A1 (en) 1992-12-30
ATE142226T1 (de) 1996-09-15
KR100243962B1 (ko) 2000-02-01
TW213468B (es) 1993-09-21
SI9200126A (en) 1992-12-31
FI106032B (fi) 2000-11-15
NO306950B1 (no) 2000-01-17
AU660682B2 (en) 1995-07-06

Similar Documents

Publication Publication Date Title
DE69100865D1 (de) 1,4,8-Triazacyclotridecan-Derivate mit Prolylendopeptidase-hemmender Wirkung.
ES2091369T3 (es) Antibioticos glucopeptidicos derivados de balhimicina.
NO174517C (es)
ES2054927T3 (es) Antibioticos glicosidicos bu-3608 d y bu-3608 e.
DE68923928D1 (de) Glykopeptid-Antibiotika.
FI922437A0 (fi) Tetracykliska antibiotika och foerfarande foer framstaellning av dessa.
NO910309D0 (no) Fremgangsmaate for fremstilling samt anvedelse av et nytt antibiotisk deoksymulundocandin.
IN171883B (es)
IN172911B (es)
RU1808695C (ru) Центрирующее захватное устройство
ES2111018T3 (es) Antibiotico ll-e19020 gamma.
ATE161847T1 (de) Antibiotikum ll-e19020 alpha
ITMI910660A1 (it) Anticorpi monoclonali come antidoti
SE8403352D0 (sv) Desacetylravidomycin
SU1823451A1 (ru) 2,3а-Дигидрокси-3-(4-толуоил)-3а,4-дигидро-1Н-пирроло[2,1-с][1, 4]бензоксазин-1,4-дион, проявляющий противомикробную активность в отношении кокковых форм бактерий

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 521408

Country of ref document: ES